Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001683168-24-008176
Filing Date
2024-11-15
Accepted
2024-11-15 16:19:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE REVISED PROXY SOLICITING MATERIALS cns_defr14a.htm DEFR14A 97322
  Complete submission text file 0001683168-24-008176.txt   98363
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-39126 | Film No.: 241468149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)